Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

N-((2,2-dimethyl-2,3-dihydrobenzofuran-7-yloxy)ethyl)-3-(cyclopent-1-enyl)benzylamine MeSH Supplementary Concept Data 2025


MeSH Supplementary
N-((2,2-dimethyl-2,3-dihydrobenzofuran-7-yloxy)ethyl)-3-(cyclopent-1-enyl)benzylamine
Unique ID
C518313
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C518313
Entry Term(s)
DDEC-benzylamine
F15063
N-((2,2-dimethyl-2,3-dihydro-benzofuran-7-yloxy)ethyl)-3-(cyclopent-1-enyl)-benzylamine
Pharm Action
Serotonin 5-HT1 Receptor Agonists
Dopamine D2 Receptor Antagonists
Registry Numbers
0
Heading Mapped to
*Benzofurans
*Benzylamines
Frequency
10
Note
an antipsychotic agent; structure in first source
Source
J Med Chem 2007 Feb 22;50(4):865-76
Date of Entry
2007/03/24
Revision Date
2015/08/18
N-((2,2-dimethyl-2,3-dihydrobenzofuran-7-yloxy)ethyl)-3-(cyclopent-1-enyl)benzylamine Preferred
F15063 Narrower
page delivered in 0.005s